SearcharxivSearch

arXiv subjects

Martin Adiels

Publications and source records attributed to Martin Adiels.

3 recordsLinked to original sources

Trajectory-guided discharge stratification for heart failure using short-context electronic health record sequence modeling

Purpose: Heart failure (HF) discharge planning depends on identifying patients at risk of deterioration or death, yet accurate prediction from routinely collected electronic health records (EHRs) remains challenging. Methods: We develop trajectory-guided discharge stratification for heart failure (TGDS-HF), a methodology that reads the patient in-hospital trajectory of diagnoses, vital signs, laboratories, medications, and procedures end-to-end with a compact short-context autoregressive Transformer, and uses it to stratify one-year risks of clinical instability (a rehospitalization phenotype) or mortality for discharge care. We instantiate TGDS-HF on a Swedish HF cohort (N = 42,820) to predict one-year clinical instability or mortality at the initial HF diagnosis in-hospital. TGDS-HF has three components: category-level tokenization, recency-weighted temporal representation, and sequence model configuration. We run ablations on these components to show the effectiveness of TGDS-HF. Results: Against traditional eXtreme gradient boosting machine (XGBoost) and bidirectional encoder representations from Transformers (BERT)-based EHR sequence-modeling baselines, TGDS-HF (Llama backbone) achieved area under the precision-recall curves (AUPRCs) with 95% confidence intervals of 0.555 (0.535-0.575) and 0.574 (0.550-0.599) across the two tasks at the method default, with robust calibration. A task-specific refinement using daily aggregation of repeated continuous events improves the mortality task to 0.582 (0.558-0.608). Further, TGDS-HF maintains strong performance under reduced clinical concept availability and limited training data. Conclusion: Combined predictions of instability and mortality from TGDS-HF may support personalized discharge planning, ranging from follow-up in primary care to specialist-led management and, when appropriate, palliative care.

cs.LG

Cost-Aware Prediction (CAP): An LLM-Enhanced Machine Learning Pipeline and Decision Support System for Heart Failure Mortality Prediction

Objective: Machine learning (ML) predictive models are often developed without considering downstream value trade-offs and clinical interpretability. This paper introduces a cost-aware prediction (CAP) framework that combines cost-benefit analysis assisted by large language model (LLM) agents to communicate the trade-offs involved in applying ML predictions. Materials and Methods: We developed an ML model predicting 1-year mortality in patients with heart failure (N = 30,021, 22% mortality) to identify those eligible for home care. We then introduced clinical impact projection (CIP) curves to visualize important cost dimensions - quality of life and healthcare provider expenses, further divided into treatment and error costs, to assess the clinical consequences of predictions. Finally, we used four LLM agents to generate patient-specific descriptions. The system was evaluated by clinicians for its decision support value. Results: The eXtreme gradient boosting (XGB) model achieved the best performance, with an area under the receiver operating characteristic curve (AUROC) of 0.804 (95% confidence interval (CI) 0.792-0.816), area under the precision-recall curve (AUPRC) of 0.529 (95% CI 0.502-0.558) and a Brier score of 0.135 (95% CI 0.130-0.140). Discussion: The CIP cost curves provided a population-level overview of cost composition across decision thresholds, whereas LLM-generated cost-benefit analysis at individual patient-levels. The system was well received according to the evaluation by clinicians. However, feedback emphasizes the need to strengthen the technical accuracy for speculative tasks. Conclusion: CAP utilizes LLM agents to integrate ML classifier outcomes and cost-benefit analysis for more transparent and interpretable decision support.

cs.LG

Investigations of a compartmental model for leucine kinetics using nonlinear mixed effects models with ordinary and stochastic differential equations

Nonlinear mixed effects models represent a powerful tool to simultaneously analyze data from several individuals. In this study a compartmental model of leucine kinetics is examined and extended with a stochastic differential equation to model non-steady state concentrations of free leucine in the plasma. Data obtained from tracer/tracee experiments for a group of healthy control individuals and a group of individuals suffering from diabetes mellitus type 2 are analyzed. We find that the interindividual variation of the model parameters is much smaller for the nonlinear mixed effects models, compared to traditional estimates obtained from each individual separately. Using the mixed effects approach, the population parameters are estimated well also when only half of the data are used for each individual. For a typical individual the amount of free leucine is predicted to vary with a standard deviation of 8.9% around a mean value during the experiment. Moreover, leucine degradation and protein uptake of leucine is smaller, proteolysis larger, and the amount of free leucine in the body is much larger for the diabetic individuals than the control individuals. In conclusion nonlinear mixed effects models offers improved estimates for model parameters in complex models based on tracer/tracee data and may be a suitable tool to reduce data sampling in clinical studies.

q-bio.QM